Sary Alsanea

681 total citations
44 papers, 491 citations indexed

About

Sary Alsanea is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Sary Alsanea has authored 44 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Pharmacology and 8 papers in Pharmacology. Recurrent topics in Sary Alsanea's work include Pharmacogenetics and Drug Metabolism (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Analytical Methods in Pharmaceuticals (3 papers). Sary Alsanea is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Analytical Methods in Pharmaceuticals (3 papers). Sary Alsanea collaborates with scholars based in Saudi Arabia, Pakistan and France. Sary Alsanea's co-authors include Dexi Liu, Ahmed Nadeem, Sheikh F. Ahmad, Sabry M. Attia, Mingming Gao, Naif O. Al‐Harbi, Faleh Alqahtani, Saleh A. Bakheet, Hafiz Majid Mahmood and Muhammad Fawad Rasool and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Nutrients.

In The Last Decade

Sary Alsanea

42 papers receiving 485 citations

Peers

Countries citing papers authored by Sary Alsanea

Since Specialization

Citations

This map shows the geographic impact of Sary Alsanea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sary Alsanea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sary Alsanea more than expected).

Fields of papers citing papers by Sary Alsanea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sary Alsanea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sary Alsanea. The network helps show where Sary Alsanea may publish in the future.

Co-authorship network of co-authors of Sary Alsanea

This figure shows the co-authorship network connecting the top 25 collaborators of Sary Alsanea. A scholar is included among the top collaborators of Sary Alsanea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sary Alsanea. Sary Alsanea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oxytocin Protects PC12 Cells Against β-Amyloid-Induced Cell Injury 2025 ·Pharmaceuticals ·Mohammed M. Alanazi, Awatif B. Albaker, (unknown), (unknown), Fawaz Alasmari, (unknown), Metab Alharbi, Abdullah F. Alasmari, Faleh Alqahtani, Sary Alsanea	0
2	Indole-3-Acetic Acid: Promising Protective Agent Against Methotrexate-Induced Liver Injury via Modulation of TLR4/NF-κB/Caspase-3 Pathway 2025 ·Pharmaceuticals ·(unknown), Ahlam M. Alhusaini, Wedad S. Sarawi, Iman H. Hasan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sary Alsanea	1
3	Evaluating the use of paracetamol to prevent fasting headache during the first week of Ramadan: A randomized, open‐label, clinical trial 2024 ·Headache The Journal of Head and Face Pain ·Omar A. Almohammed, Sary Alsanea, (unknown), (unknown), (unknown), (unknown), Fawaz Alasmari, (unknown), Mohammed A. Assiri, (unknown), (unknown), (unknown), Abdulrahman Alwhaibi	2
4	Effect of fasting-induced headache on calcitonin gene related peptide (CGRP) and other clinical biomarkers on the first day of Ramadan: Sub-analysis from a randomized open label clinical trial 2024 ·The Journal of Headache and Pain ·Abdulrahman Alwhaibi, Fawaz Alasmari, (unknown), Mohammed A. Assiri, (unknown), (unknown), (unknown), (unknown), (unknown), Omar A. Almohammed, Sary Alsanea	2
5	Unveiling the potential of perampanel and pregabalin in addressing pentylenetetrazole-induced electrographic alterations and neurobehavioral anomalies 2023 ·Biomedicine & Pharmacotherapy ·(unknown), Sana Javaid, Waseem Ashraf, Syed Muhammad Muneeb Anjum, Muhammad Fawad Rasool, Farhan Siddique, Tanveer Ahmad, Sary Alsanea, Fawaz Alasmari, Faleh Alqahtani, Imran Imran	6
6	Predicting Hydroxychloroquine Clearance in Healthy and Diseased Populations Using a Physiologically Based Pharmacokinetic Approach 2023 ·Pharmaceutics ·Faleh Alqahtani, (unknown), (unknown), Muhammad Fawad Rasool, Amer S. Alali, Sary Alsanea, Ismail A. Walbi	5
7	A Physiologically Based Pharmacokinetic Model to Predict Systemic Ondansetron Concentration in Liver Cirrhosis Patients 2023 ·Pharmaceuticals ·Faleh Alqahtani, (unknown), (unknown), (unknown), (unknown), Muhammad Fawad Rasool, (unknown), Sary Alsanea	6
8	Auranofin Modulates Thioredoxin Reductase/Nrf2 Signaling in Peripheral Immune Cells and the CNS in a Mouse Model of Relapsing–Remitting EAE 2023 ·Biomedicines ·(unknown), Naif O. Al‐Harbi, Sheikh F. Ahmad, Sabry M. Attia, Mohammad Algahtani, Khalid E. Ibrahim, Saleh A. Bakheet, Mohammed M. Alanazi, Saleh A. Alqarni, Sary Alsanea, Ahmed Nadeem	7
9	Mechanism Underlying Triple VEGFR Inhibitor Tivozanib-Induced Hypertension in Mice Model 2023 ·Pharmaceuticals ·Wael A. Alanazi, (unknown), (unknown), (unknown), Sary Alsanea, Metab Alharbi	4
10	Physiologically-based pharmacokinetic modeling for single and multiple dosing regimens of ceftriaxone in healthy and chronic kidney disease populations: a tool for model-informed precision dosing 2023 ·Frontiers in Pharmacology ·Fawaz Alasmari, (unknown), (unknown), (unknown), Abdullah F. Alasmari, Sary Alsanea, Aws Alshamsan, Muhammad Fawad Rasool, Faleh Alqahtani	9
11	Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Predicting Haloperidol Exposure in Healthy and Disease Populations 2022 ·Pharmaceutics ·(unknown), Fawaz Alasmari, Abdullah F. Alasmari, Aws Alshamsan, Sary Alsanea, Muhammad Fawad Rasool, Faleh Alqahtani	4
12	Development and Evaluation of a Physiologically Based Pharmacokinetic Model of Labetalol in Healthy and Diseased Populations 2022 ·Pharmaceutics ·(unknown), (unknown), Muhammad Fawad Rasool, Imran Imran, Hamid Saeed, Tanveer Ahmad, Sary Alsanea, Ali A. Alshamrani, (unknown), Faleh Alqahtani	11
13	Prevalence, knowledge and attitude toward electronic cigarette use among male health colleges students in Saudi Arabia—A cross-sectional study 2022 ·Frontiers in Public Health ·Sary Alsanea, Ziyad Alrabiah, (unknown), Wajid Syed, (unknown), (unknown), (unknown), Sultan Alghadeer, Abdulaziz Alhossan, Abdulrahman Alwhaibi, Mohamed N. Al-Arifi	11
14	Acetyl-11-keto-β-boswellic acid improves clinical symptoms through modulation of Nrf2 and NF-κB pathways in SJL/J mouse model of experimental autoimmune encephalomyelitis 2022 ·International Immunopharmacology ·Ahmed Nadeem, Sheikh F. Ahmad, Naif O. Al‐Harbi, Wedad S. Sarawi, Sabry M. Attia, Wael A. Alanazi, Khalid E. Ibrahim, Sary Alsanea, Saleh A. Alqarni, (unknown), Saleh A. Bakheet	20
15	Serum Proteomic Analysis of Cannabis Use Disorder in Male Patients 2021 ·Molecules ·Fawaz Alasmari, Sary Alsanea, Assim A. Alfadda, Ibrahim O. Alanazi, (unknown), Afshan Masood, Faleh Alqahtani, Omer I. Fantoukh, Abdullah F. Alasmari, Hicham Benabdelkamel	3
16	Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities 2021 ·International Journal of Molecular Sciences ·Sana Javaid, (unknown), (unknown), (unknown), Waseem Ashraf, Muhammad Fawad Rasool, Faleh Alqahtani, Sary Alsanea, Fawaz Alasmari, Mohammed M. Alanazi, Metab Alharbi, Imran Imran	35
17	Public Perception and Attitude toward Community Pharmacists in Saudi Arabia 2021 ·Omar A. Almohammed, Sary Alsanea	18
18	Exposure to the plasticizer, Di-(2-ethylhexyl) phthalate during juvenile period exacerbates autism-like behavior in adult BTBR T + tf/J mice due to DNA hypomethylation and enhanced inflammation in brain and systemic immune cells 2021 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Ahmed Nadeem, Naif O. Al‐Harbi, Sheikh F. Ahmad, Khalid Alhazzani, Sabry M. Attia, Sary Alsanea, Ali Alhoshani, Hafiz Majid Mahmood, (unknown), Saleh A. Bakheet	33
19	The Stat3 inhibitor, S3I-201, downregulates lymphocyte activation markers, chemokine receptors, and inflammatory cytokines in the BTBR T+ Itpr3tf/J mouse model of autism 2019 ·Brain Research Bulletin ·Sheikh F. Ahmad, Mushtaq Ahmad Ansari, Ahmed Nadeem, Saleh A. Bakheet, Ahmed Z. Alanazi, Sary Alsanea, Homood M. As Sobeai, Mashal M. Almutairi, Hafiz Majid Mahmood, Sabry M. Attia	16
20	BITC and S-Carvone Restrain High-Fat Diet-Induced Obesity and Ameliorate Hepatic Steatosis and Insulin Resistance 2017 ·Pharmaceutical Research ·Sary Alsanea, Dexi Liu	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact